Express Scripts Holding Co (ESRX) is Gibraltar Capital Management Inc.’s 7th Largest Position

Gibraltar Capital Management Inc. raised its holdings in Express Scripts Holding Co (NASDAQ:ESRX) by 1.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 69,247 shares of the company’s stock after purchasing an additional 969 shares during the quarter. Express Scripts accounts for approximately 5.2% of Gibraltar Capital Management Inc.’s investment portfolio, making the stock its 7th biggest position. Gibraltar Capital Management Inc.’s holdings in Express Scripts were worth $6,579,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Landaas & Co. WI ADV acquired a new stake in shares of Express Scripts during the 2nd quarter valued at $102,000. Kaizen Advisory LLC lifted its holdings in Express Scripts by 147.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after buying an additional 800 shares during the period. Adviser Investments LLC lifted its holdings in Express Scripts by 321.9% during the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after buying an additional 1,130 shares during the period. Sun Life Financial INC lifted its holdings in Express Scripts by 758.8% during the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after buying an additional 1,343 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its holdings in Express Scripts by 3,048.1% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock worth $126,000 after buying an additional 1,585 shares during the period. 84.73% of the stock is currently owned by hedge funds and other institutional investors.

In other Express Scripts news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the sale, the insider now directly owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.79% of the company’s stock.

ESRX has been the topic of several recent research reports. BidaskClub downgraded Express Scripts from a “buy” rating to a “hold” rating in a report on Tuesday, July 10th. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and lifted their target price for the stock from $90.00 to $96.50 in a report on Tuesday, September 18th. Zacks Investment Research raised Express Scripts from a “strong sell” rating to a “hold” rating in a report on Tuesday, June 26th. Royal Bank of Canada lifted their target price on Express Scripts to $94.00 and gave the stock an “outperform” rating in a report on Monday, August 27th. Finally, William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Three equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have assigned a buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and a consensus price target of $86.36.

Express Scripts stock traded up $0.52 during midday trading on Tuesday, reaching $96.12. The stock had a trading volume of 212,635 shares, compared to its average volume of 4,343,883. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. The firm has a market capitalization of $53.41 billion, a price-to-earnings ratio of 13.54, a PEG ratio of 1.20 and a beta of 1.01. Express Scripts Holding Co has a 12 month low of $55.80 and a 12 month high of $96.45.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. The firm had revenue of $25.64 billion during the quarter, compared to analyst estimates of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.73 EPS. On average, sell-side analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current year.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Stock Symbols, CUSIP and Other Stock Identifiers

Want to see what other hedge funds are holding ESRX? Visit to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with's FREE daily email newsletter.

Leave a Reply